
Keywords: Glycated albumin; Glycosylated hemoglobin; Glucose lowering medication; Taiwan; Reference range; Atherosclerosis; Prevention; ALT; Alanine aminotransferase; XGI; Alpha-Glucosidase Inhibitor; BG; Biguanides; CRE; Creatinine; DM; Diabetes Mellitus; DPP-4; D